Literature DB >> 18751418

The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.

Yo-ichi Yamashita1, Akinobu Taketomi, Kazutoyo Morita, Takasuke Fukuhara, Shigeru Ueda, Kensaku Sanefuji, Tomohiro Iguchi, Hiroto Kayashima, Keishi Sugimachi, Yoshihiko Maehara.   

Abstract

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a primary adenocarcinoma of the liver arising from the intrahepatic bile duct. Hepatectomy with extensive lymph node dissection is the standard treatment for ICC. PATIENTS AND METHODS: Sixty patients with ICC who underwent hepatectomy in our institution between 1986 and 2005 were investigated to determine prognostic factors and to evaluate the impact of surgical treatment for ICC using univariate and multivariate analyses.
RESULTS: The overall survival rate of the R0 resection group (n=43) was significantly higher than that of the R1/2 group (n=17). However, in patients with lymph node metastasis (n=24), R0 resection had no survival impact. According to multivariate analysis, the independent factors of poor prognosis were: the presence of lymph node metastasis, lymphatic invasion, poor differentiation and R1/2 resection.
CONCLUSION: R0 resection can provide prolonged survival for patients with ICC. Patients with lymph node metastasis, lymphatic invasion, or poorly differentiated ICC have poor prognosis after operation and additional treatment, such as adjuvant chemotherapy, is recommended.

Entities:  

Mesh:

Year:  2008        PMID: 18751418

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Factors affecting survival after resection of intrahepatic cholangiocarcinoma.

Authors:  Sae Murakami; Tetsuo Ajiki; Taro Okazaki; Kimihiko Ueno; Masahiro Kido; Ippei Matsumoto; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2014-01-23       Impact factor: 2.549

Review 2.  The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.

Authors:  Yuji Morine; Mitsuo Shimada
Journal:  J Gastroenterol       Date:  2015-04-02       Impact factor: 7.527

3.  Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.

Authors:  Tatsunori Miyata; Yo-Ichi Yamashita; Takanobu Yamao; Naoki Umezaki; Masayo Tsukamoto; Yuki Kitano; Kensuke Yamamura; Kota Arima; Takayoshi Kaida; Shigeki Nakagawa; Katsunori Imai; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2017-02-15       Impact factor: 3.402

4.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

5.  Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.

Authors:  Umberto Cillo; Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; Sara Lonardi; David Cosgrove; Timothy M Pawlik
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

6.  Intrahepatic cholangiocarcinoma: prognostic factors after liver resection.

Authors:  Gennaro Nuzzo; Felice Giuliante; Francesco Ardito; Agostino Maria De Rose; Maria Vellone; Gennaro Clemente; Carlo Chiarla; Ivo Giovannini
Journal:  Updates Surg       Date:  2010-08

7.  Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases.

Authors:  Wei Jiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Jian Zhou; Meng-Su Zeng; Jian-Ying Zhang; Yi-Xing Chen; Yun-Shan Tan
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-04       Impact factor: 4.553

8.  The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study.

Authors:  Tatsunori Miyata; Yo-Ichi Yamashita; Takaaki Higashi; Katsunobu Taki; Daisuke Izumi; Keisuke Kosumi; Ryuma Tokunaga; Shigeki Nakagawa; Hirohisa Okabe; Katsunori Imai; Daisuke Hashimoto; Akira Chikamoto; Hideo Baba
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

9.  Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.

Authors:  Tomohide Nakayama; Takahiro Tsuchikawa; Toshiaki Shichinohe; Toru Nakamura; Yuma Ebihara; Satoshi Hirano
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

10.  Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma.

Authors:  Chun-Nan Yeh; Feng-Jen Hsieh; Kun-Chun Chiang; Jen-Shi Chen; Ta-Sen Yeh; Yi-Yin Jan; Miin-Fu Chen
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.